Search

Uniting MSK’s research and clinical expertise with AWS’s advanced cloud technologies is a bold step towards addressing one of the world’s most pressing health challenges.

… Monday, March 10, 2025 Amazon Web Services (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN) and Memorial Sloan Kettering Cancer Center (MSK), a leading global cancer center, today announced a collaboration harnessing the power of artificial intelligence (AI), high performance computing (HPC), and other

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Wednesday, September 16, 2020 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Forbes Names Memorial Sloan Kettering Cancer Center #2 Best Employer in New York State Memorial Sloan Kettering Cancer Center MSK was named the second-best employer in New York

The May 4 session of “MSK Science Spotlight” will feature series host, Andrea Schietinger, PhD, Assistant Member, Immunology Program, SKI, presenting her own research, “Decoding T Cell Dysfunction in Tumors.” Dr. Schietinger, a former winner of the prestigious National Institutes of Health Director’s New Innovator Award, has served as host for past sessions of the online seminar series for the scientific community.

… Monday, May 4, 2020 The May 4 session of “MSK Science Spotlight” will feature series host, Andrea Schietinger, PhD , Assistant Member, Immunology Program, SKI, presenting her own research, “Decoding T Cell Dysfunction in Tumors.” Dr. Schietinger, a former winner of the prestigious National Institutes

Researchers shed light on how aberrant cell division can cause the kind of mutations often found in cancer cells.

… Thursday, August 27, 2020 VIDEO | 00:16 Separation Anxiety: Cell Division Gone Awry Leads to Genetic Chaos This video shows the effects of telomere crisis during cell division. As a cell attempts to divide, a tug-of-war develops over the chromosome (narrow strand) as each daughter cell tries to claim

An MSK research team aims to find new ways to stop the most common and deadly form of ovarian cancer — high-grade serous ovarian cancer — from recurring with the help of a method they developed for tracking the evolution of treatment resistant cells in ovarian cancer using blood tests.

… Wednesday, October 1, 2025 Several factors make  ovarian cancer particularly challenging to treat. This is largely because the cancer often spreads at a microscopic level within the abdomen early on, resulting in diagnosis at an advanced stage. Additionally, while initial treatments with surgery, chemotherapy

David Solit, MD, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, is the featured speaker for the June 3 episode of “MSK Science Spotlight.”

… Wednesday, June 3, 2020 David Solit, MD , Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology , is the featured speaker for the June 3 episode of “MSK Science Spotlight.” Dr. Solit, a physician-scientist who studies human oncology and pathogenesis, genomics, oncogenes and tumor

Cytoreductive surgery for advanced ovarian cancer is safe in older women, even those who present with frailty.

… Thursday, September 19, 2019 Cytoreductive surgery for advanced ovarian cancer is safe in older women, even those who present with frailty, according to our recent prospective study of 42 patients treated at Memorial Sloan Kettering Cancer Center. Despite a high rate of preoperative impairments, there

Memorial Sloan Kettering Cancer Center (MSK) is now recognized as the first dedicated cancer center in the United States to be designated as a qualified provider-led entity (QPLE) under Medicare’s program for appropriate use criteria (AUC). This designation allows MSK to establish best practice standards for the use of CT scans, MRI, and nuclear medicine imaging from initial screening and diagnosis through all stages of cancer care, including survivorship.

… Tuesday, September 19, 2017 New York, NY - Memorial Sloan Kettering Cancer Center (MSK) has become the first dedicated cancer center in the U.S. to be designated a qualified provider-led entity (QPLE) under the Medicare Appropriate Use Criteria (AUC) program. This designation allows MSK to establish

Joan Massagué, Chair of the Cancer Biology and Genetics Program in the Sloan Kettering Institute, has been named the recipient of two prestigious awards.

… Friday, May 1, 2009 Summary Joan Massagué, Chair of the Cancer Biology and Genetics Program in the Sloan Kettering Institute, has been named the recipient of two prestigious awards. Joan Massagué , Chair of the Cancer Biology and Genetics Program in the Sloan Kettering Institute , has been named the

Research led by Josie Robertson Investigator Karuna Ganesh provided clues that microbiomes might explain the increase in colorectal cancer among younger patients.

… Wednesday, April 19, 2023 At a worldwide gathering of the American Association for Cancer Research (AACR), Memorial Sloan Kettering Cancer Center (MSK) scientists presented new insights into the connection between cancer and the gut microbiome, often referred to as the “forgotten organ.” Their findings